fintepla
ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptice, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.
clofelin-zdorovie comprimate 0,15 mg
zdorovie srl, companie farmaceutica - clonidinum - comprimate - 0,15 mg
oltar comprimate 2 mg
menarini international operations luxembourg sa - comprimate - 2 mg
oltar comprimate 4 mg
menarini international operations luxembourg sa - comprimate - 4 mg
fintepla
millmount healthcare ltd - irlanda - fenfluraminum - sol. orala - 2,2mg/ml - antiepileptice alte antiepileptice
glibenclamid-zdorovie comprimate 5 mg
zdorovie srl, companie farmaceutica - glibenclamidum - comprimate - 5 mg
glimepirida accord 1 mg
accord healthcare limited - glimepiridum - compr. - 1mg - antidiabetice orale si parenterale , exclusiv insuline sulfonamide, derivati de uree
glimepirida accord 2 mg
accord healthcare limited - glimepiridum - compr. - 2mg - antidiabetice orale si parenterale , exclusiv insuline sulfonamide, derivati de uree
glimepirida accord 3 mg
accord healthcare limited - glimepiridum - compr. - 3mg - antidiabetice orale si parenterale , exclusiv insuline sulfonamide, derivati de uree
glimepirida accord 4mg
accord healthcare limited - glimepiridum - compr. - 4mg - antidiabetice orale si parenterale , exclusiv insuline sulfonamide, derivati de uree